Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

[Neuropathology of multiple sclerosis].
Monoclonal antibody therapies for the treatment of relapsing-remitting multiple sclerosis: differentiating mechanisms and clinical outcomes.
Responsiveness to reduced dosage of rituximab in Chinese patients with neuromyelitis optica.
Altered cardiovascular reactivity to mental stress in patients with multiple sclerosis.
Optimization of electron microscopy for human brains with long-term fixation and fixed-frozen sections.
Does Lipoic Acid Consumption Affect the Cytokine Profile in Multiple Sclerosis Patients: A Double-Blind, Placebo-Controlled, Randomized Clinical Trial.
CD98 is a potential target for ablating B cell clonal expansion and autoantibody in multiple sclerosis.
Extracellular vesicles as modulators of cell-to-cell communication in the healthy and diseased brain.
Bone Marrow-Derived Stem Cells and Strategies for Treatment of Nervous System Disorders: Many Protocols, and Many Results.
Teva Presents New Clinical Safety Data in RRMS Patients Treated with Laquinimod for Two or More Years at Joint ACTRIMS-ECTRIMS Meeting
A PheWAS approach in studying HLA-DRB1*1501.
Risk factors for idiopathic optic neuritis recurrence.
Il-1β Dependent Cerebellar Synaptopathy in a Mouse Mode of Multiple Sclerosis.
Exposure to serotonin adversely affects oligodendrocyte development and myelination in vitro.
Interleukin-34 restores blood-brain barrier integrity by upregulating tight junction proteins in endothelial cells.
Neurodegenerative diseases and therapeutic strategies using iron chelators.
Predictors of survival and functional outcomes in natalizumab-associated progressive multifocal leukoencephalopathy.
Development of Activity-Related Muscle Fatigue during Robot-Mediated Upper Limb Rehabilitation Training in Persons with Multiple Sclerosis: A Pilot Trial.
MHC2TA mRNA levels and human herpesvirus 6 in multiple sclerosis patients treated with interferon beta along two-year follow-up.
Preferential uptake of antioxidant carbon nanoparticles by T lymphocytes for immunomodulation.
Neuromyelitis optica and aquaporin-4 (AQP4) autoantibodies in consecutive optic neuritis patients in Southern Finland.
Characterizing cognitive function during relapse in multiple sclerosis.
Natalizumab Continued Past 24 Months Safely in MS
MicroRNA-145 as one negative regulator of astrogliosis.
Response to letter regarding article 'Fingolimod effects on left ventricular function in multiple sclerosis'.

Pages